(Q36411896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Evaluation of bromodeoxyuridine in glioblastoma multiforme: A A Northern California cancer center phase II study (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

21 October 2022

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

21 October 2022

author name string

T. L. Phillips

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

V. A. Levin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

D. K. Ahn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

P. H. Gutin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

R. L. Davis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

C. B. Wilson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

M. D. Prados

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

W. M. Wara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

M. S. Flam

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651306

21 October 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:0360301691906906?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

https://api.elsevier.com/content/article/PII:0360301691906906?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

International Journal of Radiation Oncology Biology Physics

21 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

709-714

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

Intra-arterial 5-bromodeoxyuridine and x-ray therapy

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications

21 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Genetics of human cell lines. III. Incorporation of 5-bromo- and 5-iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Radiosensitization of Malignant Brain Tumours with Bromouridine (Thymidine Analogue)

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Nonparametric Estimation from Incomplete Observations

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

A phase i study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Correlation of exposure time, concentration and incorporation of IdUrd in V-79 cells with radiation response

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90690-6

21 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651306%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference